Global Health has received affirmation in credit ratings from CRISIL Ratings pursuant to merger of Medanta Holdings (MHPL), erstwhile wholly owned subsidiary with the Company as per below details: Total Bank Loan Facilities Rated - Rs. 1500 crore* (Enhanced from Rs. 950 crore) Long Term Rating - CRISIL AA-/Positive (Reaffirmed) Short-term rating - CRISIL A1+ (Reaffirmed)*Earlier rating of MHPL was for Rs. 550 crore which was added in approved limit of GHL i.e. Rs. 950 crore. Powered by Capital Market - Live News

Global Health has received reaffirmation in credit rating for bank facilities of Rs 950 crore at CRISIL AA-; Positive/ CRISIL A1+. Powered by Capital Market - Live News

Net profit of Global Health rose 15.59% to Rs 142.91 crore in the quarter ended December 2024 as against Rs 123.64 crore during the previous quarter ended December 2023. Sales rose 12.79% to Rs 943.44 crore in the quarter ended December 2024 as against Rs 836.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales943.44836.45 13 OPM %25.2025.82 - PBDT237.51216.35 10 PBT189.07172.37 10 NP142.91123.64 16 Powered by Capital Market - Live News

Global Health will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live News

Net profit of Global Health rose 4.54% to Rs 130.84 crore in the quarter ended September 2024 as against Rs 125.16 crore during the previous quarter ended September 2023. Sales rose 13.34% to Rs 956.56 crore in the quarter ended September 2024 as against Rs 843.94 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales956.56843.94 13 OPM %23.8625.22 - PBDT230.53213.51 8 PBT181.10170.60 6 NP130.84125.16 5 Powered by Capital Market - Live News